86.22.Z - Specialist medical practice
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.90.E - Healthcare
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 3,6 | 14,1 | 291,8 |
EBITDA | 1,1 | 3,7 | 14,3 | 289,8 |
Short time liabilities | 3,8 | 2,8 | 2,4 | -12,3 |
Equity capital | 1 | 6,4 | 10,5 | 64,5 |
Operating profit (EBIT) | 1 | 3,6 | 14,1 | 291,8 |
Assets | 4,9 | 9,1 | 12,9 | 41,3 |
Net profit (loss) | 1 | 3,6 | 14,1 | 291,8 |
Cash | 1,3 | 0,8 | 2,8 | 247,6 |
Net income from sale | 25,1 | 42,4 | 62,3 | 47 |
Liabilities and provisions for liabilities | 3,8 | 2,8 | 2,4 | -12,3 |
Working assets | 4,8 | 8,7 | 12,6 | 44,9 |
Depreciation | 0,1 | 0,1 | 0,2 | 185,5 |
% | % | % | p.p. | |
Profitability of capital | 97,1 | 56,3 | 134,2 | 77,9 |
Equity capital to total assets | 21,3 | 69,9 | 81,3 | 11,4 |
Gross profit margin | 4 | 8,5 | 22,6 | 14,1 |
EBITDA Margin | 4,5 | 8,6 | 22,9 | 14,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 56 | 24 | 14 | -10 |
Current financial liquidity indicator | 1.2406225204467773 | 3.16394305229187 | 5.2244720458984375 | 2 |
Net dept to EBITDA | -1.127943515777588 | -0.21686136722564697 | -0.19335566461086273 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane